Replies to post #1659 on Tetraphase Pharmaceuticals, Inc. (TTPH)

[Schnauzer1]

In the universe of antibiotic players this is the king! TTPH has 3000 synthetic derivatives of tetracycline already created and in the lab. That is possible only because it has the ONLY synthetic method of manufacturing. As soon as the market has the time to understand the reason for the miss on the P3 for cUTI was food interference with oral delivery, and the new probabilities that a repeat performance of the P3 for inter-abdominal infection is better than 90% probability (given high pass rate of prior trial pass rate) (the new criteria for NDA acceptance by FDA) then it's "to the moon Alice"! Of course, some people need 100%. But those guys aren't in equities anyway.

So, expecting $5 is really not getting the picture of the value of this stock! Looking down the field a ways I see the value being caught by price! Just a matter of patience! Warren B trueism